Chirhostim Synthetic Human Secretin syringe

A Family Run Company

ChiRhoClin, Inc., a Maryland based family run corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products.


Jean Purich, RN
Read Bio
Jean Purich RN
  • Chief Financial Officer
Skip Purich, MBA
Read Bio
Skip Purich MBA
  • Chief Executive Officer


  1. Develop orphan theranostic drug products for the Gastrointestinal, Pediatric, and Radiological community that will diagnose or treat pancreatic and gastrointestinal diseases.
  2. Create a culture of scientific exchange emphasizing research in acute and chronic pancreatitis, pancreatic cancer, gastrointestinal imaging, and genetic testing.
  3. Donate time, energy, and resources to encourage pancreatic research though our pancreatic grant program.
The concept of drug treatment of the pancreas


ChiRhoClin, Inc. received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin.  Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market ChiRhoStim® (Synthetic Human Secretin for injection).  

Contact us

We make it easy to get started. Let us know how we can get you on your way.